Analyst Price Targets — LMRI
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 20, 2026 9:15 am | — | Barclays | $9.00 | $7.00 | TheFly | Lumexa Imaging price target lowered to $9 from $15 at Barclays |
| April 14, 2026 9:40 am | — | Barclays | $15.00 | $9.67 | TheFly | Lumexa Imaging price target lowered to $15 from $23 at Barclays |
| January 5, 2026 12:54 pm | — | Barclays | $23.00 | $17.55 | TheFly | Lumexa Imaging initiated with an Overweight at Barclays |
| January 5, 2026 12:08 pm | — | Deutsche Bank | $22.00 | $17.55 | TheFly | Lumexa Imaging initiated with a Buy at Deutsche Bank |
| January 5, 2026 11:37 am | — | Leerink Partners | $23.00 | $17.55 | TheFly | Lumexa Imaging initiated with an Outperform at Leerink |
| January 5, 2026 11:11 am | — | Raymond James | $23.00 | $17.55 | TheFly | Lumexa Imaging initiated with an Outperform at Raymond James |
| January 5, 2026 10:31 am | — | Wells Fargo | $22.00 | $17.55 | TheFly | Lumexa Imaging initiated with an Overweight at Wells Fargo |
| January 5, 2026 10:13 am | — | H.C. Wainwright | $22.00 | $17.55 | StreetInsider | Wells Fargo Starts Lumexa Imaging Holdings (LMRI) at Overweight |
| January 5, 2026 9:52 am | — | Jefferies | $23.00 | $17.55 | TheFly | Lumexa Imaging initiated with a Buy at Jefferies |
Latest News for LMRI
The mean of analysts' price targets for Lumexa (LMRI) points to a 44.1% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
The consensus price target hints at a 73.3% upside potential for Lumexa (LMRI). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
RALEIGH, N.C., June 02, 2026 (GLOBE NEWSWIRE) -- Lumexa Imaging (NASDAQ: LMRI), one of the nation's largest providers of outpatient imaging services, today announced the formation of a strategic joint venture with Hospital for Special Surgery (HSS), world leader in musculoskeletal health.
Lumexa Imaging Holdings, Inc. (LMRI) Q1 2026 Earnings Call Transcript
Lumexa Imaging NASDAQ: LMRI reported first-quarter results that management said were in line with expectations, as growth in advanced imaging modalities helped offset seasonal volume pressure and weather-related disruptions.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for LMRI.
U.S. House Trading
No House trades found for LMRI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.